chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Bell's palsy
Clinical narrative: Systemic: Bell's Palsy-Severe, Systemic: Exhaustion / Lethargy-Medium, Additional Details: Md called to report incdent .According to the provider patient had reaction to the vaccine she received  , Bells palsy. Md confirmed that he is treating  patient. RPH was able to reach out to patient and discuessed  her concernas well . Patient has Rx filled for tramadol,valtrex and prednisone,from same dr today at the Pharmacy location patient usually goes
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Cardiac septal defect, Heart rate decreased, Seizure, Seizure like phenomena, Syncope
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Seizure-Medium, Additional Details: 10:28 - Following administration of vaccine, patient while still sitting in the chair had an episode of syncope with seizure-like activities  which lasted for 10 secs. 10:30 - Patient regained consciousness at which point EMS was activated and call placed to patient's mother to notify her of the situation. Serial vital signs done with HR noted to be in the low 30's to 40's. (See vital sign documentation). Patient admitted to having a cardiac defect-Bicupsid Aortic. recovered,EMS released home
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Seizure-Medium, Additional Details: 10:28 - Following administration of vaccine, patient while still sitting in the chair had an episode of syncope with seizure-like activities  which lasted for 10 secs. 10:30 - Patient regained consciousness at which point EMS was activated and call placed to patient's mother to notify her of the situation. Serial vital signs done with HR noted to be in the low 30's to 40's. (See vital sign documentation). Patient admitted to having a cardiac defect-Bicupsid Aortic. recovered,EMS released home
Age: 34.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Morphoea, Skin mass, Swelling
Clinical narrative: the patient describes large red swelling after the vaccination, which then resolved and left a lump under the skin. On examination, the lump is visible under the skin, and there is a white patch over the lump and red discoloration of the skin.  Similar in appearance to morphea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Amenorrhoea, Arthralgia, Asthma, Brain fog, Fatigue
Clinical narrative: Thoracic spine pain, stiffness, inflammation; Amenorrhea, Cervical spine stiffness, SI Joint pain, inflammation, stiffness, Tension headaches, Asthma, Brain fog, Sinusitis, Extreme Fatigue, Welts on face
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Inflammation, Musculoskeletal stiffness, Sinusitis, Spinal pain, Tension headache
Clinical narrative: Thoracic spine pain, stiffness, inflammation; Amenorrhea, Cervical spine stiffness, SI Joint pain, inflammation, stiffness, Tension headaches, Asthma, Brain fog, Sinusitis, Extreme Fatigue, Welts on face
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Urticaria
Clinical narrative: Thoracic spine pain, stiffness, inflammation; Amenorrhea, Cervical spine stiffness, SI Joint pain, inflammation, stiffness, Tension headaches, Asthma, Brain fog, Sinusitis, Extreme Fatigue, Welts on face
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Decreased appetite, Fatigue, Headache, Myalgia
Clinical narrative: TIREDNESS, SLIGHT HEADACHE, MUSCLE ACHES, LACK OF APPETITE; ONGOING AS OF JUNE 10, 10:45 AM.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Culture urine, Micturition urgency, Pollakiuria, Urine analysis abnormal, White blood cells urine positive
Clinical narrative: Urinary frequency and urgency started on June 3 (one day after COVID  injection) and ended  June 8, six days after injection.  Urinalysis showed large amounts of white blood cells which I feel is from inflammation of my bladder and urethra from the COVID vaccine.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Chest pain, Dyspnoea
Clinical narrative: The patient and his wife got their 2nd Shingrix vaccine on Thursday morning.  Starting Friday morning, the patient started having chest pain which led to breathing problems. His wife called a triage nurse and was instructed to call EMS. The patient is currently in the hospital getting stabilized. Currently the patient is stable, but still in the hospital.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity, Product administration error
Clinical narrative: Patient states when she was given the Shingrix vaccine on 4/16/2023 she had a sore arm afterwards. She has no redness or swelling. Her arm is achy when she tries to lift it or move it. She has difficulty sleeping on that arm as well. She has not tried any OTC pain relievers or prescription medications. She has tried to rub and massage that arm with no relief. I mentioned using ice and she is going to try that as well. She went to her doctor for a recent checkup and they had no further recommendations. They stated mostly likely we hit the bone and should use a smaller needle. I told the patient I would follow up with her weekly to see how she is feeling. She is concerned about getting her next vaccine but I said it will be her choice to finish the series.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Biopsy, Pruritus, Scab
Clinical narrative: This was 4th covid vaccine (second booster) but all others were Pfizer - this was the first Moderna.  A little over 2 weeks I started itching very badly all over my body.  Been to doctors and dermotoligsts and taking antihistamines, steroids and creams.  I am still itchy all the time with scabs all over my body including my head.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered, No adverse event
Clinical narrative: no adverse event happened - patient got an extra dose of shingrix on 6/10/2023- on reporting system, it reported that he had gotten shingles vaccine on 7/9/2019 and 9/14/2019. The doses reported were 0.65ml on both. It was assumed he had gotten zostavax with extra dose as an error. After verification, it was learned he had gotten shingrix.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Mobility decreased
Clinical narrative: Patient called 4 hours later to say she cannot move her arm. Immunization was given correctly.
Age: 12.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Fall, Syncope
Clinical narrative: approx 2 min post administration, pt was sitting on exam bed, fell forward, face first, healthcare staff present in room during vasovagal, called for help and EMS transported to Hospital.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Muscle tightness, Urticaria, Vaccination site induration, Vaccination site swelling
Clinical narrative: On 5/25/23 pt. seen in reported local reaction to vaccine. Pt seen in office on 5/25 by MD. MD reported at site of vaccine-- swelling, hard, red, tight, perhaps some SOB, no wheezing, no cough, no fevers, felt hives internally. MD recommended OTC antihistamine with icing for swelling, referred to allergy for evaluation. Allergy PA noted that local reaction was most likely due to the Prevnar 20 vaccine and that pt. can continue icing.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Discomfort, Fall, Foot fracture, Fracture
Clinical narrative: When I woke up 24 hours after the booster shot, I had NO feeling in feet, ankles, or lower legs. It took several months and doctors to diagnose Guillain-Barré syndrome (GBS). I am now getting IVIG infusions; however, NO improvement has been noticed. In the meantime I broke my foot trying to walk on numb feet.  On 12/21/22 I was seen by my primary care physician for extensive bloodwork. On 1/5/23 I fell in the night and broke my foot and was taken by ambulance to the emergency room. Although I have no true feeling in my feet I do now suffer from extreme pain and discomfort at night. I have had to resort to a wheelchair for mobility out of the house and a walker inside. Bone fracture was assessed as healed in early March. On 3/8/23 I saw neurologist Dr. and had a nerve conduction study. Dr. scheduled an MRI on 3/25/23. Dr. also ordered additional blood work, urine test, and follow-up on 4/11/23. IVIG infusions were approved following formal diagnosis.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Magnetic resonance imaging
Clinical narrative: When I woke up 24 hours after the booster shot, I had NO feeling in feet, ankles, or lower legs. It took several months and doctors to diagnose Guillain-Barré syndrome (GBS). I am now getting IVIG infusions; however, NO improvement has been noticed. In the meantime I broke my foot trying to walk on numb feet.  On 12/21/22 I was seen by my primary care physician for extensive bloodwork. On 1/5/23 I fell in the night and broke my foot and was taken by ambulance to the emergency room. Although I have no true feeling in my feet I do now suffer from extreme pain and discomfort at night. I have had to resort to a wheelchair for mobility out of the house and a walker inside. Bone fracture was assessed as healed in early March. On 3/8/23 I saw neurologist Dr. and had a nerve conduction study. Dr. scheduled an MRI on 3/25/23. Dr. also ordered additional blood work, urine test, and follow-up on 4/11/23. IVIG infusions were approved following formal diagnosis.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nerve conduction studies, Pain, Urine analysis, Walking aid user, Wheelchair user
Clinical narrative: When I woke up 24 hours after the booster shot, I had NO feeling in feet, ankles, or lower legs. It took several months and doctors to diagnose Guillain-Barré syndrome (GBS). I am now getting IVIG infusions; however, NO improvement has been noticed. In the meantime I broke my foot trying to walk on numb feet.  On 12/21/22 I was seen by my primary care physician for extensive bloodwork. On 1/5/23 I fell in the night and broke my foot and was taken by ambulance to the emergency room. Although I have no true feeling in my feet I do now suffer from extreme pain and discomfort at night. I have had to resort to a wheelchair for mobility out of the house and a walker inside. Bone fracture was assessed as healed in early March. On 3/8/23 I saw neurologist Dr. and had a nerve conduction study. Dr. scheduled an MRI on 3/25/23. Dr. also ordered additional blood work, urine test, and follow-up on 4/11/23. IVIG infusions were approved following formal diagnosis.
Age: 80.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Fatigue, Hypersensitivity, Skin warm, Swelling
Clinical narrative: From MD Chart note:   The patient had seen me on May 24th for her Prevnar 20, which was a Wednesday  and then the following Tuesday on May 30th, she developed erythema and swelling.  She went to urgent care for evaluation on May 30th and was advised to monitor  it.  She then called the on-call doctor last night, Dr., who felt it  was probably allergic reaction.  As a result, she took 50 mg of Benadryl and  reports significant improvement throughout this period.  Again, the initial  reaction was about a week after the injection.  She had no fevers or chills.   There is no drainage.  It is not sore.  It felt hot, not really a welt kind of  reaction, just generalized swelling in a well demarcated area, but an irregular  shape.  No respiratory symptoms and again with the Benadryl, she is improved.   She does report some fatigue. MPRESSION AND PLAN: Likely, allergic reaction, certainly possible after injection, but the timing of it happening 1 week later is what is atypical.  Fortunately, she has no  respiratory symptoms and she did improve and respond to an antihistamine.   Therefore, I recommend that she continue the Benadryl 50 mg tid, alerting her  for symptoms of drowsiness, although she does not drive if she is drowsy and she can use ice, over-the-counter topical hydrocortisone and if her symptoms worsen, she is advised to followup.  I have offered allergy consultation, but she defers for now.  It does not appear to be infectious, especially as it is improved with the antihistamine.  We may mark this is an allergy in the future and avoid  Prevnar 20 in the future.  Follow up call by RN on 6/9. Pt. reports improvement, has stopped taking anithistamine, denies pain, denies SOB, denies wheezing.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: RASH THAT SEEMS TO BE SPREADING. PT ARRIVED AT PHARMACY ASKING FOR REMEDY. PHARMACIST RECOMMENDED BENADRYL TABLETS AND TO SEE DOCTOR IF IT GETS WORSE.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: The patient received a vaccine that had not been stored properly.  Rather than storing under refrigeration upon receipt from the manufacturer, the vaccine was placed into a freezer that maintained temperatures between -4- and 5-degrees Fahrenheit.  Guidance from the manufacturer states that while administration of a vaccine having undergone this temperature excursion would not cause harm to the patient, the effectiveness of the vaccine cannot be verified.  No harm has been reported by this patient and they have been notified that the Department of Health recommends being revaccinated at their earliest convenience.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Discomfort, Pain in jaw, Trismus
Clinical narrative: PATIENT EXPERIENCED LOCKING UP OF JAW ON RIGHT SIDE.  IT REMAINED LOCKED FOR  ABOUT ONE MINUTE. HE WORKED AT A CHEWING MOTION UNTIL IT FINALLY LOOSED UP FULLY.  HE WAS AT LUNCH AT THE TIME AND IT REAMINED PAINFUL AND UNCOMORTABLE THROUGH OUT THE MEAL. HE REPORTS THAT THE JAW REAIMED SORE FOR SERVEAL DAYS BEFORE RESOLVING.  NO MEDICAL TREATMENTS OR MEDICATIONS USED.  THE SAME REACTION OCCURRED AFTER THE 2ND DOSE ON 3/17/2023. THIS TIME IT WAS ABOUT A WEEK WEEK LATER WHEN THE SAME RIGHT SIDE OF JAW; SAME OUTCOME AND TREATMENT.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Unevaluable event
Clinical narrative: For not wearing mask to be taken over, which is not spread over onto our society. To attend college or university, I need to be removed the wearing mask.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Swelling
Clinical narrative: Pt reports swelling, redness, itchiness at sight of injection. There was noticeable swelling
Age: 11.0
Sex: M
Vaccine: DTAP, HPV9
Symptoms: Cellulitis, Erythema
Clinical narrative: mother claimed son received HPV, DTAP and Meningococcal in the same arm at the same time to MA and then told me she received 2 shots and was unable to verbalize what they were. DNP FNP BC
Age: 29.0
Sex: F
Vaccine: YF
Symptoms: Hypersensitivity, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient is experiencing increased redness, tenderness and a bump increasing in size at the injection site one-week after injection. Pharmacist recommended that patient go to Urgent Care to receive care for potential allergic reaction.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain, Chills, Fatigue, Headache, Injection site erythema
Clinical narrative: *Pain (feels like a bruise), swelling ~one inch below injection site and about one inch in diameter and red *Fatigue *Headache *Shivering *Fever 101.1 *Unexplained belly pain *Unexplained all-over muscle pain in back At this writing, at 7:15 p.m., June 10, 2023, patient is no longer experiencing headache, shivering, belly pain.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site swelling, Myalgia, Pyrexia
Clinical narrative: *Pain (feels like a bruise), swelling ~one inch below injection site and about one inch in diameter and red *Fatigue *Headache *Shivering *Fever 101.1 *Unexplained belly pain *Unexplained all-over muscle pain in back At this writing, at 7:15 p.m., June 10, 2023, patient is no longer experiencing headache, shivering, belly pain.
Age: 12.0
Sex: F
Vaccine: FLU4, HPV9, MNQ
Symptoms: Asthenia, Dizziness, Nausea
Clinical narrative: pt felt weak, dizzy, nauseous, monitored by provider until patient ambulated out of clinic unassisted
Age: 13.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal X-ray, Abdominal pain, Abdominal tenderness, Flushing, Influenza virus test
Clinical narrative: Moderna Bivalent vaccine was administered at 11 am, At 12:20 pm the patient developed abdominal pain, vomiting, diffuse flushing involving arms/legs/trunk/face, and hives. He was given Benadryl at 3:45 pm but flushing of skin worsened. He presented to the Emergency Department at 7:30 pm. Findings notable for diffuse flushing and abdominal tenderness to palpation diffusely. Vitals were normal. He did not have angioedema, hives, or wheezing,
Age: 13.0
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory pathogen panel, SARS-CoV-2 test positive, Urticaria, Vomiting
Clinical narrative: Moderna Bivalent vaccine was administered at 11 am, At 12:20 pm the patient developed abdominal pain, vomiting, diffuse flushing involving arms/legs/trunk/face, and hives. He was given Benadryl at 3:45 pm but flushing of skin worsened. He presented to the Emergency Department at 7:30 pm. Findings notable for diffuse flushing and abdominal tenderness to palpation diffusely. Vitals were normal. He did not have angioedema, hives, or wheezing,
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Chills, Fatigue, Headache, Hot flush, Injection site pain
Clinical narrative: Fatigue, headache, soreness at injection site started almost right away. Followed by hot flashes/chills and nausea later in the day. 5 days later a non itchy rash has appeared on face.  Nausea, head ache, and Fatigue are better but still present after 5 days. Taking Tylenol or ibuprofen to manage soreness and headache. Benedryl for the rash
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Nausea, Rash
Clinical narrative: Fatigue, headache, soreness at injection site started almost right away. Followed by hot flashes/chills and nausea later in the day. 5 days later a non itchy rash has appeared on face.  Nausea, head ache, and Fatigue are better but still present after 5 days. Taking Tylenol or ibuprofen to manage soreness and headache. Benedryl for the rash
Age: 11.0
Sex: F
Vaccine: HPV9, TDAP
Symptoms: Discomfort, Injection site erythema
Clinical narrative: 1cm of redness on upper left arm. Non tender, and no discharge. We advise to apply ice & give Benadryl. Pt was uncomfortable
Age: 19.0
Sex: M
Vaccine: MENB
Symptoms: Erythema, Mass, Tenderness
Clinical narrative: Red spot, tender to touch and a lump.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Anal incontinence, Aphasia, Bladder catheterisation, Bladder disorder, Bladder dysfunction
Clinical narrative: Blood clot on left brain causing paralysis on right side and loss of speech and loss of bladder function. Can no longer walk or control bowels. Severely depressed. Has catheter since 12/1/2023 that has destroyed his penis and bladder.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral thrombosis, Depression, Device physical property issue, Gait inability, Hemiplegia
Clinical narrative: Blood clot on left brain causing paralysis on right side and loss of speech and loss of bladder function. Can no longer walk or control bowels. Severely depressed. Has catheter since 12/1/2023 that has destroyed his penis and bladder.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Penis disorder
Clinical narrative: Blood clot on left brain causing paralysis on right side and loss of speech and loss of bladder function. Can no longer walk or control bowels. Severely depressed. Has catheter since 12/1/2023 that has destroyed his penis and bladder.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site bruising, Injection site discolouration, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: 1st time getting Pfizer vaccine, Pt has a history of getting the Moderna vaccine. Upon immunization on 05/31, the injection site became red and swollen. The pt was given Benadryl and instructed to take Ibuprofen. On 06/03, the patient presented with redness/warmth at the site and continued to take Benadryl twice daily & Ibuprofen every 4-6 hrs. On 06/06, the site was bruised and yellow, no redness or swelling present.
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 22.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dizziness, Flushing, Hyperhidrosis, Nausea, Visual impairment
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Medium, Additional Details: We helped the patient to lay down & had him lay flat for 15 minutes, at which point he started feeling much better. He remained conscious & drank some Body Armor. We checked BP, which was 129/78 before he left. Patient had a friend with him & she drove him home. Patient was unsure of PCP name & contact info, but I recommended that he call PCP tomorrow.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness, Migraine, Nausea, Tinnitus
Clinical narrative: The morning after the injection I woke up with nausea followed by an all-day migraine ending in the evening. Then on the 4th day after the injection, I began to hear electrical noises.  I was then diagnosed with Tinnitus and hearing loss by an Ear Nose & Throat Specialist in 3/2021.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Fatigue, Nasopharyngitis
Clinical narrative: I had a mild case of Covid. I had a 2 days of fever, body aches and cold symptoms. After taking Paxlovid, I was tired and I lost my sense of smell 100% and taste probably 70%.  I felt better after a few days, but didn't regain smell and taste for about 3-4 weeks.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: I had a mild case of Covid. I had a 2 days of fever, body aches and cold symptoms. After taking Paxlovid, I was tired and I lost my sense of smell 100% and taste probably 70%.  I felt better after a few days, but didn't regain smell and taste for about 3-4 weeks.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Fatigue, Nausea, Pyrexia
Clinical narrative: FEVER, CHILLS, TIREDNESS, NAUESA, WENT AWAY, DIZZYNESS
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Influenza like illness, Injection site pain, Myalgia
Clinical narrative: Pain at injection site immediately.  Flu like symptoms that evening and next day.  Muscle pain throughout body and joint pain in bearing joints on the second day following
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Nausea
Clinical narrative: EXTREME CHILLS, TIREDNESS , NAUSEA,
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint stiffness, X-ray limb
Clinical narrative: Next day after vaccination BOTH knees were aching and this continued on post vaccination for several months until I went to the PRIVACY Physician to  check out this development, xrays were taken ,  Previous to the vaccinations neither knees were in pain.  I had to corticosteroid injections which relieved the issue until the my third vaccination when it occurred again .  I have continues stiffness and pain in both knees.  Please note prior to these vaccinations I had NO pain in my knees.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Injection site pain, Myalgia
Clinical narrative: Headache, muscle aches, shivering, pain at injection site,
Age: 57.0
Sex: F
Vaccine: HEP
Symptoms: Arthralgia, Neck pain, Pain, Pain in extremity
Clinical narrative: Patient had severe pain and throbbing in shoulder/neck and arm starting the day after the vaccine. Patient states pain lasted for 2-3 weeks.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Injection site swelling, Pruritus
Clinical narrative: Swelling at and around injection site..itching running up and down arm....redness
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Brain fog, Fatigue, Myalgia, Post-acute COVID-19 syndrome
Clinical narrative: First 12 hours felt great. During the next 24 hours, experienced blurry vision, Intense Joint/Muscle Aches Pain. Complaint of cognitive fog. Fatigue. Symptoms previously experienced with self reported Long covid.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vision blurred
Clinical narrative: First 12 hours felt great. During the next 24 hours, experienced blurry vision, Intense Joint/Muscle Aches Pain. Complaint of cognitive fog. Fatigue. Symptoms previously experienced with self reported Long covid.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine, Blood culture negative, Blood glucose increased
Clinical narrative: Patient is a 75 y.o. female patient with history of prolymphocytic leukemia on ibrutinib, breast cancer, IDDM, HTN, depression, OSA who presented to Medical Center with acute dyspnea.   Acute on chronic hypoxemic respiratory failure-resolved SO2 ~60s on-site ; baseline on 3L Due to COVID, possible superimposed bacterial pneumonia CT on admission showed B/L consolidations in lower lobes B/L Intubated in ED MAP (mmHg):  [88-115] 95 Pulm following Extubated  3/24; doing well on RA 3/26 at rest and on ambulation     Septic Shock-resolved P/w fever, tachycardia, resp failure, shock Likely due to UTI mainly; can't r/o superimposed bacterial PNA although less likely WBC wnl; Lactate wnl BCx NTD; UCx as below On Vanc and Cefepime since admission On Levo since admission; off 3/24 am MRSA probe +ve     Covid-19 Virus Infection CAP Date of onset of symptoms: 3/22 Symptoms present on admission: dyspnea Date of covid positive test: 3/22 Vaccination status: vaccinated Imaging: CT as above Oxygen requirements on admission: ventilator Current oxygen requirements: ventilator Medical therapy: steroids; ABx as above MRS Probe +ve Consultants following: Pulm Anticipated special isolation end date: 4/2Acute UTI UA is grossly positive Ucx >100k CRE Klebs susceptible to Cefepime No acute CTAP findings Could change to PO Cipro on dc(End 3/29)   AKI-resolving Developed 3/23 with Cr sharply up to 1.2 from wnl  Likely ATN due to shock Non-oliguric Peaked at 1.4 then improved     IDDM; uncontrolled A1C 6.6 BG >200 here due to steroids Home lantus 35u HS continued Improved   HTN Hold home amlodipine for shock Resumed as BP high   B cell prolymphocytic leukemia Hold ibrutinib for now while critically ill   Chronic pain syndrome Holding home percoset, gabapentin, zanaflex while on ICU sedation, resume as able   Depression Continue duloxetine
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood lactic acid normal, COVID-19, Computerised tomogram thorax abnormal, Condition aggravated, Critical illness
Clinical narrative: Patient is a 75 y.o. female patient with history of prolymphocytic leukemia on ibrutinib, breast cancer, IDDM, HTN, depression, OSA who presented to Medical Center with acute dyspnea.   Acute on chronic hypoxemic respiratory failure-resolved SO2 ~60s on-site ; baseline on 3L Due to COVID, possible superimposed bacterial pneumonia CT on admission showed B/L consolidations in lower lobes B/L Intubated in ED MAP (mmHg):  [88-115] 95 Pulm following Extubated  3/24; doing well on RA 3/26 at rest and on ambulation     Septic Shock-resolved P/w fever, tachycardia, resp failure, shock Likely due to UTI mainly; can't r/o superimposed bacterial PNA although less likely WBC wnl; Lactate wnl BCx NTD; UCx as below On Vanc and Cefepime since admission On Levo since admission; off 3/24 am MRSA probe +ve     Covid-19 Virus Infection CAP Date of onset of symptoms: 3/22 Symptoms present on admission: dyspnea Date of covid positive test: 3/22 Vaccination status: vaccinated Imaging: CT as above Oxygen requirements on admission: ventilator Current oxygen requirements: ventilator Medical therapy: steroids; ABx as above MRS Probe +ve Consultants following: Pulm Anticipated special isolation end date: 4/2Acute UTI UA is grossly positive Ucx >100k CRE Klebs susceptible to Cefepime No acute CTAP findings Could change to PO Cipro on dc(End 3/29)   AKI-resolving Developed 3/23 with Cr sharply up to 1.2 from wnl  Likely ATN due to shock Non-oliguric Peaked at 1.4 then improved     IDDM; uncontrolled A1C 6.6 BG >200 here due to steroids Home lantus 35u HS continued Improved   HTN Hold home amlodipine for shock Resumed as BP high   B cell prolymphocytic leukemia Hold ibrutinib for now while critically ill   Chronic pain syndrome Holding home percoset, gabapentin, zanaflex while on ICU sedation, resume as able   Depression Continue duloxetine
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Culture urine positive, Depression, Diabetes mellitus inadequate control, Dyspnoea, Endotracheal intubation
Clinical narrative: Patient is a 75 y.o. female patient with history of prolymphocytic leukemia on ibrutinib, breast cancer, IDDM, HTN, depression, OSA who presented to Medical Center with acute dyspnea.   Acute on chronic hypoxemic respiratory failure-resolved SO2 ~60s on-site ; baseline on 3L Due to COVID, possible superimposed bacterial pneumonia CT on admission showed B/L consolidations in lower lobes B/L Intubated in ED MAP (mmHg):  [88-115] 95 Pulm following Extubated  3/24; doing well on RA 3/26 at rest and on ambulation     Septic Shock-resolved P/w fever, tachycardia, resp failure, shock Likely due to UTI mainly; can't r/o superimposed bacterial PNA although less likely WBC wnl; Lactate wnl BCx NTD; UCx as below On Vanc and Cefepime since admission On Levo since admission; off 3/24 am MRSA probe +ve     Covid-19 Virus Infection CAP Date of onset of symptoms: 3/22 Symptoms present on admission: dyspnea Date of covid positive test: 3/22 Vaccination status: vaccinated Imaging: CT as above Oxygen requirements on admission: ventilator Current oxygen requirements: ventilator Medical therapy: steroids; ABx as above MRS Probe +ve Consultants following: Pulm Anticipated special isolation end date: 4/2Acute UTI UA is grossly positive Ucx >100k CRE Klebs susceptible to Cefepime No acute CTAP findings Could change to PO Cipro on dc(End 3/29)   AKI-resolving Developed 3/23 with Cr sharply up to 1.2 from wnl  Likely ATN due to shock Non-oliguric Peaked at 1.4 then improved     IDDM; uncontrolled A1C 6.6 BG >200 here due to steroids Home lantus 35u HS continued Improved   HTN Hold home amlodipine for shock Resumed as BP high   B cell prolymphocytic leukemia Hold ibrutinib for now while critically ill   Chronic pain syndrome Holding home percoset, gabapentin, zanaflex while on ICU sedation, resume as able   Depression Continue duloxetine
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Glycosylated haemoglobin normal, Hypertension, Intensive care, Lung consolidation, Malaise
Clinical narrative: Patient is a 75 y.o. female patient with history of prolymphocytic leukemia on ibrutinib, breast cancer, IDDM, HTN, depression, OSA who presented to Medical Center with acute dyspnea.   Acute on chronic hypoxemic respiratory failure-resolved SO2 ~60s on-site ; baseline on 3L Due to COVID, possible superimposed bacterial pneumonia CT on admission showed B/L consolidations in lower lobes B/L Intubated in ED MAP (mmHg):  [88-115] 95 Pulm following Extubated  3/24; doing well on RA 3/26 at rest and on ambulation     Septic Shock-resolved P/w fever, tachycardia, resp failure, shock Likely due to UTI mainly; can't r/o superimposed bacterial PNA although less likely WBC wnl; Lactate wnl BCx NTD; UCx as below On Vanc and Cefepime since admission On Levo since admission; off 3/24 am MRSA probe +ve     Covid-19 Virus Infection CAP Date of onset of symptoms: 3/22 Symptoms present on admission: dyspnea Date of covid positive test: 3/22 Vaccination status: vaccinated Imaging: CT as above Oxygen requirements on admission: ventilator Current oxygen requirements: ventilator Medical therapy: steroids; ABx as above MRS Probe +ve Consultants following: Pulm Anticipated special isolation end date: 4/2Acute UTI UA is grossly positive Ucx >100k CRE Klebs susceptible to Cefepime No acute CTAP findings Could change to PO Cipro on dc(End 3/29)   AKI-resolving Developed 3/23 with Cr sharply up to 1.2 from wnl  Likely ATN due to shock Non-oliguric Peaked at 1.4 then improved     IDDM; uncontrolled A1C 6.6 BG >200 here due to steroids Home lantus 35u HS continued Improved   HTN Hold home amlodipine for shock Resumed as BP high   B cell prolymphocytic leukemia Hold ibrutinib for now while critically ill   Chronic pain syndrome Holding home percoset, gabapentin, zanaflex while on ICU sedation, resume as able   Depression Continue duloxetine
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Mechanical ventilation, Pneumonia, Pyrexia, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 75 y.o. female patient with history of prolymphocytic leukemia on ibrutinib, breast cancer, IDDM, HTN, depression, OSA who presented to Medical Center with acute dyspnea.   Acute on chronic hypoxemic respiratory failure-resolved SO2 ~60s on-site ; baseline on 3L Due to COVID, possible superimposed bacterial pneumonia CT on admission showed B/L consolidations in lower lobes B/L Intubated in ED MAP (mmHg):  [88-115] 95 Pulm following Extubated  3/24; doing well on RA 3/26 at rest and on ambulation     Septic Shock-resolved P/w fever, tachycardia, resp failure, shock Likely due to UTI mainly; can't r/o superimposed bacterial PNA although less likely WBC wnl; Lactate wnl BCx NTD; UCx as below On Vanc and Cefepime since admission On Levo since admission; off 3/24 am MRSA probe +ve     Covid-19 Virus Infection CAP Date of onset of symptoms: 3/22 Symptoms present on admission: dyspnea Date of covid positive test: 3/22 Vaccination status: vaccinated Imaging: CT as above Oxygen requirements on admission: ventilator Current oxygen requirements: ventilator Medical therapy: steroids; ABx as above MRS Probe +ve Consultants following: Pulm Anticipated special isolation end date: 4/2Acute UTI UA is grossly positive Ucx >100k CRE Klebs susceptible to Cefepime No acute CTAP findings Could change to PO Cipro on dc(End 3/29)   AKI-resolving Developed 3/23 with Cr sharply up to 1.2 from wnl  Likely ATN due to shock Non-oliguric Peaked at 1.4 then improved     IDDM; uncontrolled A1C 6.6 BG >200 here due to steroids Home lantus 35u HS continued Improved   HTN Hold home amlodipine for shock Resumed as BP high   B cell prolymphocytic leukemia Hold ibrutinib for now while critically ill   Chronic pain syndrome Holding home percoset, gabapentin, zanaflex while on ICU sedation, resume as able   Depression Continue duloxetine
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Septic shock, Shock, Staphylococcus test positive, Tachycardia, Urinary tract infection
Clinical narrative: Patient is a 75 y.o. female patient with history of prolymphocytic leukemia on ibrutinib, breast cancer, IDDM, HTN, depression, OSA who presented to Medical Center with acute dyspnea.   Acute on chronic hypoxemic respiratory failure-resolved SO2 ~60s on-site ; baseline on 3L Due to COVID, possible superimposed bacterial pneumonia CT on admission showed B/L consolidations in lower lobes B/L Intubated in ED MAP (mmHg):  [88-115] 95 Pulm following Extubated  3/24; doing well on RA 3/26 at rest and on ambulation     Septic Shock-resolved P/w fever, tachycardia, resp failure, shock Likely due to UTI mainly; can't r/o superimposed bacterial PNA although less likely WBC wnl; Lactate wnl BCx NTD; UCx as below On Vanc and Cefepime since admission On Levo since admission; off 3/24 am MRSA probe +ve     Covid-19 Virus Infection CAP Date of onset of symptoms: 3/22 Symptoms present on admission: dyspnea Date of covid positive test: 3/22 Vaccination status: vaccinated Imaging: CT as above Oxygen requirements on admission: ventilator Current oxygen requirements: ventilator Medical therapy: steroids; ABx as above MRS Probe +ve Consultants following: Pulm Anticipated special isolation end date: 4/2Acute UTI UA is grossly positive Ucx >100k CRE Klebs susceptible to Cefepime No acute CTAP findings Could change to PO Cipro on dc(End 3/29)   AKI-resolving Developed 3/23 with Cr sharply up to 1.2 from wnl  Likely ATN due to shock Non-oliguric Peaked at 1.4 then improved     IDDM; uncontrolled A1C 6.6 BG >200 here due to steroids Home lantus 35u HS continued Improved   HTN Hold home amlodipine for shock Resumed as BP high   B cell prolymphocytic leukemia Hold ibrutinib for now while critically ill   Chronic pain syndrome Holding home percoset, gabapentin, zanaflex while on ICU sedation, resume as able   Depression Continue duloxetine
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urine analysis abnormal, White blood cell count normal
Clinical narrative: Patient is a 75 y.o. female patient with history of prolymphocytic leukemia on ibrutinib, breast cancer, IDDM, HTN, depression, OSA who presented to Medical Center with acute dyspnea.   Acute on chronic hypoxemic respiratory failure-resolved SO2 ~60s on-site ; baseline on 3L Due to COVID, possible superimposed bacterial pneumonia CT on admission showed B/L consolidations in lower lobes B/L Intubated in ED MAP (mmHg):  [88-115] 95 Pulm following Extubated  3/24; doing well on RA 3/26 at rest and on ambulation     Septic Shock-resolved P/w fever, tachycardia, resp failure, shock Likely due to UTI mainly; can't r/o superimposed bacterial PNA although less likely WBC wnl; Lactate wnl BCx NTD; UCx as below On Vanc and Cefepime since admission On Levo since admission; off 3/24 am MRSA probe +ve     Covid-19 Virus Infection CAP Date of onset of symptoms: 3/22 Symptoms present on admission: dyspnea Date of covid positive test: 3/22 Vaccination status: vaccinated Imaging: CT as above Oxygen requirements on admission: ventilator Current oxygen requirements: ventilator Medical therapy: steroids; ABx as above MRS Probe +ve Consultants following: Pulm Anticipated special isolation end date: 4/2Acute UTI UA is grossly positive Ucx >100k CRE Klebs susceptible to Cefepime No acute CTAP findings Could change to PO Cipro on dc(End 3/29)   AKI-resolving Developed 3/23 with Cr sharply up to 1.2 from wnl  Likely ATN due to shock Non-oliguric Peaked at 1.4 then improved     IDDM; uncontrolled A1C 6.6 BG >200 here due to steroids Home lantus 35u HS continued Improved   HTN Hold home amlodipine for shock Resumed as BP high   B cell prolymphocytic leukemia Hold ibrutinib for now while critically ill   Chronic pain syndrome Holding home percoset, gabapentin, zanaflex while on ICU sedation, resume as able   Depression Continue duloxetine
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Blood culture negative, COVID-19, Chest X-ray normal, Computerised tomogram head normal
Clinical narrative: Patient is a 79 y.o. male patient of, MD with a history of fall   Discharge Diagnoses:   1. Covid-19 Virus Infection 1. Date of onset of symptoms: 3/11/23 (nasal congestion) 2. Symptoms present on admission: nasal congestion and ear ache 3. Date of covid positive test:  3/17/2023 4. Vaccination status:  vaccinated and boosters (x5) 5. Imaging:   CXR no acute process   6. Anticipated special isolation end date 3/27/2023   Dizziness and fall H/O HTN, CAD, CAB Overweight with BMI 39 HOH     Pulmonary hypertension appreciated on echo; follow up with pcp.    Patient reports that on Friday his legs just felt like they were too weak he was able to get up and went to the bathroom but then fell.  He reports that he did not lose consciousness.  Head CT in the ER was negative.  Patient reports that he just felt generally weak.  ER noted he had a fever of 100.  Blood cultures all negative.  Was found to have COVID-19.  States that he had symptoms starting on the 11th.  He denied any shortness of breath.  Chest x-ray was unremarkable.  He is not requiring oxygen.  Outside window for antivirals.  Patient has been vaccinated.  Was initiated on oral Decadron.  Due to his hypertension also added hydralazine..  Due to dizziness he was having an echo was completed and was found to have pulmonary hypertension for which he states he will follow-up outpatient with Dr. as he no longer follows with his cardiologist
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dizziness, Ear pain, Echocardiogram abnormal, Fall, Muscular weakness
Clinical narrative: Patient is a 79 y.o. male patient of, MD with a history of fall   Discharge Diagnoses:   1. Covid-19 Virus Infection 1. Date of onset of symptoms: 3/11/23 (nasal congestion) 2. Symptoms present on admission: nasal congestion and ear ache 3. Date of covid positive test:  3/17/2023 4. Vaccination status:  vaccinated and boosters (x5) 5. Imaging:   CXR no acute process   6. Anticipated special isolation end date 3/27/2023   Dizziness and fall H/O HTN, CAD, CAB Overweight with BMI 39 HOH     Pulmonary hypertension appreciated on echo; follow up with pcp.    Patient reports that on Friday his legs just felt like they were too weak he was able to get up and went to the bathroom but then fell.  He reports that he did not lose consciousness.  Head CT in the ER was negative.  Patient reports that he just felt generally weak.  ER noted he had a fever of 100.  Blood cultures all negative.  Was found to have COVID-19.  States that he had symptoms starting on the 11th.  He denied any shortness of breath.  Chest x-ray was unremarkable.  He is not requiring oxygen.  Outside window for antivirals.  Patient has been vaccinated.  Was initiated on oral Decadron.  Due to his hypertension also added hydralazine..  Due to dizziness he was having an echo was completed and was found to have pulmonary hypertension for which he states he will follow-up outpatient with Dr. as he no longer follows with his cardiologist
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasal congestion, Pulmonary hypertension, SARS-CoV-2 test positive
Clinical narrative: Patient is a 79 y.o. male patient of, MD with a history of fall   Discharge Diagnoses:   1. Covid-19 Virus Infection 1. Date of onset of symptoms: 3/11/23 (nasal congestion) 2. Symptoms present on admission: nasal congestion and ear ache 3. Date of covid positive test:  3/17/2023 4. Vaccination status:  vaccinated and boosters (x5) 5. Imaging:   CXR no acute process   6. Anticipated special isolation end date 3/27/2023   Dizziness and fall H/O HTN, CAD, CAB Overweight with BMI 39 HOH     Pulmonary hypertension appreciated on echo; follow up with pcp.    Patient reports that on Friday his legs just felt like they were too weak he was able to get up and went to the bathroom but then fell.  He reports that he did not lose consciousness.  Head CT in the ER was negative.  Patient reports that he just felt generally weak.  ER noted he had a fever of 100.  Blood cultures all negative.  Was found to have COVID-19.  States that he had symptoms starting on the 11th.  He denied any shortness of breath.  Chest x-ray was unremarkable.  He is not requiring oxygen.  Outside window for antivirals.  Patient has been vaccinated.  Was initiated on oral Decadron.  Due to his hypertension also added hydralazine..  Due to dizziness he was having an echo was completed and was found to have pulmonary hypertension for which he states he will follow-up outpatient with Dr. as he no longer follows with his cardiologist
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abstains from alcohol, Acute respiratory failure, Affective disorder, COVID-19, Cough
Clinical narrative: 56 y.o. female patient with history of HTN, HLD, anxiety, tobacco and etoh dependence presented to Hospital with dyspnea, found to have Covid and hypoxia   Acute hypoxic respiratory failure  Due to covid, and possible chronic lung disease  IS, wean as able May want to leave to take care of her cats, social work consulted for possible home 02  Recommend outpatient pulmonary function testing   Covid 19  2 days of cough, dyspnea  Requiring 4L 02 on admission, no baseline 02 requirement  Vaccinated x2, last 2021   Xray clear, PCR postiive 3/16  Cont dexamethasone, started remdesivir on admission Currently on RA, but with desaturations on ambulation Home O2, dexamethasone and albuterol  on discharge   Hyponatremia Hydration overnight    Tobacco dependence  NRT    EtOH dependence  Sober 2 months, no hx withdrawal  On opt vivitrol    Mood disorder Cont home escitalopram, atarax prn    HTN Cont BB   HLD  Statin
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Hyperlipidaemia, Hypertension, Hyponatraemia, Hypoxia
Clinical narrative: 56 y.o. female patient with history of HTN, HLD, anxiety, tobacco and etoh dependence presented to Hospital with dyspnea, found to have Covid and hypoxia   Acute hypoxic respiratory failure  Due to covid, and possible chronic lung disease  IS, wean as able May want to leave to take care of her cats, social work consulted for possible home 02  Recommend outpatient pulmonary function testing   Covid 19  2 days of cough, dyspnea  Requiring 4L 02 on admission, no baseline 02 requirement  Vaccinated x2, last 2021   Xray clear, PCR postiive 3/16  Cont dexamethasone, started remdesivir on admission Currently on RA, but with desaturations on ambulation Home O2, dexamethasone and albuterol  on discharge   Hyponatremia Hydration overnight    Tobacco dependence  NRT    EtOH dependence  Sober 2 months, no hx withdrawal  On opt vivitrol    Mood disorder Cont home escitalopram, atarax prn    HTN Cont BB   HLD  Statin
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, SARS-CoV-2 test positive, Tobacco abuse, X-ray normal
Clinical narrative: 56 y.o. female patient with history of HTN, HLD, anxiety, tobacco and etoh dependence presented to Hospital with dyspnea, found to have Covid and hypoxia   Acute hypoxic respiratory failure  Due to covid, and possible chronic lung disease  IS, wean as able May want to leave to take care of her cats, social work consulted for possible home 02  Recommend outpatient pulmonary function testing   Covid 19  2 days of cough, dyspnea  Requiring 4L 02 on admission, no baseline 02 requirement  Vaccinated x2, last 2021   Xray clear, PCR postiive 3/16  Cont dexamethasone, started remdesivir on admission Currently on RA, but with desaturations on ambulation Home O2, dexamethasone and albuterol  on discharge   Hyponatremia Hydration overnight    Tobacco dependence  NRT    EtOH dependence  Sober 2 months, no hx withdrawal  On opt vivitrol    Mood disorder Cont home escitalopram, atarax prn    HTN Cont BB   HLD  Statin
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Blood creatinine increased, Blood lactic acid increased, COVID-19, Chronic kidney disease
Clinical narrative: Patient is a 86 y.o. female patient of a MD with history of recently diagnosed with COVID-pneumonia, diabetes mellitus type 2 requiring insulin, anemia, hypertension presented to a local Hospital with mechanical fall hence the admission..   Mechanical fall No loss of consciousness or head injury. CT head shows no acute intracranial abnormality No history of syncope/near syncope Imaging showed no acute fracture/subluxation Evaluated by PT/OT, DC to SNF   Diabetes mellitus type 2. Continue home regimen after discharge   Lab Results Component Value Date   HGBA1C 7.3 (H) 03/29/2023    COVID-19 positive test (COVID-19)  Community-acquired pneumonia Patient recently started on Paxlovid And requiring 2 L of nasal cannula oxygen Started on dexamethasone and Levaquin Elevated procalcitonin We will continue dexamethasone x10 days,  Levaquin 750 mg every 48 hour Mucinex, as needed bronchodilators She is currently requiring on and off 2 L nasal cannula oxygen No evidence of respiratory distress, no accessory muscle We will DC to SNF with follow-up with PCP Data positive test 3/26//2023 Treatment: Was on Paxlovid, currently on steroids and Levaquin Estimated discontinuation of isolation 4/05/2023 AKI Baseline likely stage III CKD, with SCR~1.0 Was admitted with SCR 1.39, improved with IV fluids  Lactic acidosis?resolved Reported to be 2.2>1.3   Decubitus ulcer POA Wound care consulted